Briefs: Dr. Reddy's Laboratories and Torrent Pharmaceuticals
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
The acquisition is based on an enterprise value of Rs. 1,660 crore
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
The company has entered into a long-term lease and operations and management agreement with Sree Chand Specialty Hospital, situated in Kannur
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
The emergence of new infections in India is a growing concern
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Q1 FY25 revenues up 20% YoY to Rs. 1,002 crore
Subscribe To Our Newsletter & Stay Updated